Faith Davies, MD, MBBCh, MRCP, FRCPath, is a Professor working within the NYU Grossman school of medicine and the Director of Perlmutter Cancer Center’s Clinical Myeloma Program at NYU Langone Health. Dr Davies earned her medical degree from the University of Wales College of Medicine before completing her general medical training in Cardiff and Birmingham, and hematology specialty training in Leeds and London.
Prior to taking on her current appointment at NYU Langone Health in 2019, she was Medical Director of the Myeloma Institute and Professor of Medicine at the University of Arkansas for Medical Sciences. Dr Davies is a member of the British Society of Haematology, the American Society of Hematology, the American Association for Cancer Research, the Royal College of Physicians, UK, and the Royal College of Pathologists, UK. Her vast research record has seen her become a world-recognized authority in multiple myeloma, and she has published over 250 peer-reviewed articles.
Speaking on genetics, biology and novel treatment of myeloma
Dr Davies has recognized expertise in the treatment and research of multiple myeloma. Her work concentrates on the genetics, biology and novel treatment of myeloma, with a particular interest in early phase clinical trials. She aims to uncover innovative therapeutic targets that can be pursued in the development of potential new drugs and genetic technologies. Focused on individualized treatment, Dr Davies’ current research is looking into genetic, biological and radiological theranostic markers to better patient treatment options and outcomes.